{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:39:12Z","timestamp":1781534352084,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/igc.0b013e31823bd6db","type":"journal-article","created":{"date-parts":[[2012,1,7]],"date-time":"2012-01-07T07:43:25Z","timestamp":1325922205000},"page":"245-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Significance of Perioperative Infection in Survival of Patients With Ovarian Cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina P.","family":"Prather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward H.","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele L.","family":"Eno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Tierney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie A.","family":"Yessaian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight D.","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil B.","family":"Rosenshein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31823bd6db_bb0005","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0010","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0015","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0030","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ygyno.2009.03.011","article-title":"Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: a systematic review","volume":"114","author":"Gerestein","year":"2009","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0035","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1002\/ijc.24654","article-title":"Low drug resistance to both platinum and taxane chemotherapy on an in vitro drug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer","volume":"125","author":"Matsuo","year":"2009","journal-title":"IntJ Cancer."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0045","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1517\/13543784.2010.515585","article-title":"Overcoming platinum resistance in ovarian carcinoma","volume":"19","author":"Matsuo","year":"2010","journal-title":"Expert Opin Investig Drugs."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0050","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1378\/chest.118.2.503","article-title":"Proinflammatory cytokines","volume":"118","author":"Dinarello","year":"2000","journal-title":"Chest."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0055","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1158\/0008-5472.CAN-05-3948","article-title":"TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer","volume":"66","author":"Kelly","year":"2006","journal-title":"Cancer Res."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0060","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0897.1997.tb00192.x","article-title":"Review: cytokine involvement in ovarian processes","volume":"37","author":"Terranova","year":"1997","journal-title":"Am J Reprod Immunol."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0065","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1289\/ehp.0800439","article-title":"Endotoxin and cancer","volume":"117","author":"Lundin","year":"2009","journal-title":"Environ Health Perspect."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0070","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.coph.2009.06.020","article-title":"Inflammation and cancer: how friendly is the relationship for cancer patients?","volume":"9","author":"Aggarwal","year":"2009","journal-title":"Curr Opin Pharmacol."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0075","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-065X.2008.00615.x","article-title":"Is interleukin-1 a good or bad \u2018guy\u2019 in tumor immunobiology and immunotherapy?","volume":"222","author":"Apte","year":"2008","journal-title":"Immunol Rev."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0080","first-page":"931","article-title":"Serum interleukin 1 in ovarian cancer patients","volume":"34","author":"Zeisler","year":"1998","journal-title":"Eur J Cancer."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0085","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/sj.bjc.6604942","article-title":"Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system","volume":"100","author":"Killeen","year":"2009","journal-title":"Br J Cancer."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0090","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0095","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer","volume":"102","author":"Sato","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2008.01.010","article-title":"Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer","volume":"109","author":"Shah","year":"2008","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0105","first-page":"4766","article-title":"Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer","volume":"61","author":"Woo","year":"2001","journal-title":"Cancer Res."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0110","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.2009.27.2369","article-title":"Immunotherapy for ovarian cancer: what\u2019s next?","volume":"29","author":"Kandalaft","year":"2011","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0115","first-page":"235","article-title":"Cellular and humoral defence mechanisms against bacteria","volume":"1","author":"Fleer","year":"2000","journal-title":"Paediatr Respir Rev."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0120","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0003-4975(10)63221-3","article-title":"Empyema following lung cancer resection: risk factors and prognostic value on survival","volume":"33","author":"Pastorino","year":"1982","journal-title":"Ann Thorac Surg."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0125","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJM197211162872004","article-title":"Postoperative empyema improves survival in lung cancer. Documentation and analysis of a natural experiment","volume":"287","author":"Ruckdeschel","year":"1972","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0b013e31823bd6db_bb0130","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24058341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24058341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:09:32Z","timestamp":1753229372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24058341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1048891X24058341"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31823bd6db","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significance of Perioperative Infection in Survival of Patients With Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31823bd6db","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}